Aequus Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AQSZF research report →
Price Chart
About the company
Aequus Pharmaceuticals Inc. is a specialized Canadian pharmaceutical company dedicated to advancing and commercializing therapeutic solutions. Its core operations span critical areas such as neurology, ophthalmology, and transplantation.
- CEO
- Douglas Glen Janzen
- IPO
- 2015
- Employees
- 12
- HQ
- Vancouver, BC, CA
Get TickerSpark's AI analysis on AQSZF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $39.79K
- P/E
- 3.13
- PEG
- 0.02
- P/S
- 1.41
- P/B
- -0.10
- EV/EBITDA
- 15.62
- Div Yield
- 0.00%
- Gross Margin
- 50.97%
- Op Margin
- -38.19%
- Net Margin
- 43.95%
- ROE
- -2.92%
- ROIC
- 20.76%
Latest fiscal year · YoY change
- Revenue
- $584.24K+129.2%
- Gross Profit
- $332.30K+131.3%
- Op Income
- $-2,127,199
- Net Income
- $-2,177,662+26.5%
- EPS
- $-0.02+26.8%
- OCF Growth
- +27.8%
- FCF Growth
- +27.8%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.21
- RSI (14)
- 24
- Avg Volume
- 26.69K
No earnings-call transcripts are available for AQSZF yet.
- Free Float
- 85.3%
- Shares Outstanding
- 132.63M
- Float Shares
- 113.16M
Our AQSZF coverage
Recent articles, reports, and earnings notes.
No research on AQSZF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AQSZF report →Aequus Announces Completion of Previously Announced Sale of ZIMED(R) PF
thenewswire.com · Mar 31
Aequus Provides Additional Disclosure in Connection with Annual General and Special Meeting of Shareholders
thenewswire.com · Nov 13
Aequus Provides Additional Disclosure in Connection with Annual General and Special Meeting of Shareholders
thenewswire.com · Nov 12
Aequus Announces Giovanni Di Genova Joining Board of Directors
thenewswire.com · Sep 22
Aequus Reports First Quarter 2025 Financial Highlights
thenewswire.com · May 21
Aequus Reports Second Quarter 2023 Financial Highlights and General Update
globenewswire.com · Aug 29
Aequus Announces Zimed PF Now Available in Canada
globenewswire.com · Aug 24
Aequus Announces Zimed PF Website Launch
globenewswire.com · Aug 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.